The Fifth Annual Ophthalmology Summit provides a forum for addressing key issues impacting the ophthalmic field and a platform to showcase the most promising private ophthalmic companies. WilmerHale Partner David Redlick was a featured speaker on the panel, “Going Public – Who, When, and Why?” at this event. Additional panelists include representatives from JP Morgan, Alimera Science, Clarus Ventures, Stephens, Inc. and Ophthotech.
View a video of the panel discussion.
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.
